Idiopathic Thrombocytopenic Purpura (ITP) in Children

When a seemingly healthy child suddenly develops unexplained bruises and tiny red spots on their skin, parents naturally become concerned. In many cases, this could indicate idiopathic thrombocytopenic purpura (ITP), a blood disorder that affects the body’s ability to form clots. While the name sounds alarming, understanding ITP helps healthcare providers and families manage this condition effectively. This article explores what ITP means for children and the essential nursing interventions that support their recovery.

What is idiopathic thrombocytopenic purpura? 🔗

Idiopathic thrombocytopenic purpura is a blood disorder characterized by an abnormal decrease in the number of platelets in the blood. Platelets are essential blood cells that help stop bleeding by forming clots. When platelet counts drop significantly, children become susceptible to easy bruising, bleeding gums, and potentially internal bleeding.

Breaking down the term helps explain the condition: “idiopathic” means the cause is unknown, “thrombocytopenia” refers to a decreased number of platelets, and “purpura” describes the purple discoloration of the skin caused by blood leaking under it. Today, many clinicians also refer to this condition as immune thrombocytopenia because it involves the immune system attacking healthy platelets.

Understanding the pathophysiology 🔗

ITP is fundamentally an autoimmune disorder. The body’s immune system, which normally protects against infections, mistakenly produces antibodies that attach to platelet cells. The body then recognizes these antibody-coated platelets as foreign invaders and destroys them, primarily in the spleen. While the bone marrow responds by producing many more platelets, they survive only a few hours compared to the normal platelet lifespan of 7 to 10 days. This continuous cycle of production and destruction results in persistently low platelet counts.

Who does ITP affect? 🔗

ITP primarily affects young children, with acute thrombocytopenic purpura most commonly seen in children aged 2 to 6 years old. The disorder affects approximately four to eight per 100,000 children under age 15 each year in the United States. According to Boston Children’s Hospital, at least 3,000 children under the age of 16 develop ITP annually in the country.

There are two main forms of ITP:

Acute thrombocytopenic purpura: This form typically has a sudden onset and affects young children most frequently. Symptoms usually follow a viral illness and often disappear within six months or even a few weeks. Acute ITP generally does not recur and represents the most common form of the disorder in pediatric patients.

Chronic thrombocytopenic purpura: This form can begin at any age, with symptoms lasting at least twelve months. While adults develop chronic ITP more often, it does affect adolescents. Females are two to three times more likely than males to develop chronic ITP, and the condition requires ongoing follow-up with a hematologist.

Common causes and triggers 🔗

Although the exact cause of ITP remains unknown, certain patterns have been identified. Children often develop ITP approximately two to three weeks after experiencing a viral infection such as an upper respiratory illness or chickenpox. Researchers believe that when the body produces antibodies to fight the virus, it may accidentally produce an antibody that can stick to platelet cells, triggering their destruction.

It is important for families to understand that ITP is not contagious. A child cannot catch it from playing with another child who has the condition. Additionally, nothing the parents or child did caused the disorder.

Recognizing the signs and symptoms 🔗

Normal platelet counts range from 150,000 to 450,000 per microliter of blood. In children with ITP, the platelet count typically falls below 100,000, and may drop below 10,000 by the time significant bleeding occurs. The lower the platelet count, the greater the risk of bleeding.

Key symptoms to watch for include:

Petechiae: These are tiny red dots under the skin resulting from very small bleeds. Unlike rashes, petechiae do not blanch or disappear when the skin is pressed. They commonly appear on the legs, trunk, and in skin folds.

Purpura and bruising: Children may develop large purple areas or bruises without any known injury. Bruises can appear at joints like the elbows and knees simply from normal movement.

Epistaxis (nosebleeds): Frequent or prolonged nosebleeds are common in children with low platelet counts.

Gum bleeding: Children may experience spontaneous bleeding from the gums or in the mouth.

Other bleeding: Blood may appear in urine, stool, or vomit. Girls who have started menstruating may experience unusually heavy periods.

The most dangerous complication is bleeding in the head, which can be life-threatening if there are insufficient platelets to stop the bleeding. Fortunately, intracranial hemorrhage occurs in less than 1% of pediatric ITP cases.

Diagnostic approach 🔗

Diagnosis begins with a thorough medical history and physical examination. Children with typical ITP generally appear well except for bruises and petechiae. They do not typically have hepatosplenomegaly (enlarged liver or spleen), pallor, or jaundice.

Essential diagnostic tests include:

Complete blood count (CBC): This is the key laboratory finding. According to Children’s National Hospital, normal platelet counts range from 150,000 to 450,000 per microliter, but children with ITP often have platelet counts below 100,000 and sometimes below 10,000.

Peripheral blood smear: A sample of blood is examined under a microscope to check if blood cells appear normal. In ITP, platelets are reduced in number but tend to appear large.

Additional tests: Blood and urine tests may be performed to measure bleeding time and detect possible infections.

Bone marrow aspiration: This test is performed in some cases to examine platelet production and rule out other conditions like leukemia that can also cause low platelet counts.

Treatment options 🔗

Not all children with ITP require treatment. According to American Society of Hematology guidelines, children with newly diagnosed ITP who have no or minor bleeding may be managed through observation rather than immediate medication. Most children recover spontaneously without treatment, with platelet counts returning to normal within two to four days in many cases.

When treatment becomes necessary due to significant bleeding or very low platelet counts, options include:

Corticosteroids 🔗

Steroids such as prednisone help prevent bleeding by decreasing the rate of platelet destruction. Approximately 75% of children respond to steroids, with platelets recovering to safe levels within 2 to 7 days. The American Society of Hematology recommends a 5 to 7 day course of prednisone at 2 to 4 mg/kg daily. Side effects may include irritability, stomach irritation, weight gain, and mood changes.

Intravenous immunoglobulin (IVIG) 🔗

IVIG contains antibodies that slow platelet destruction. It works more quickly than steroids, typically within 24 to 48 hours. This option is often chosen when a rapid increase in platelet count is needed.

Anti-D immunoglobulin 🔗

This medication temporarily prevents the spleen from destroying platelets. It is used carefully in Rh-positive children with intact spleens because it may also destroy some red blood cells.

Other treatments 🔗

For chronic ITP that does not respond to first-line therapies, additional options include thrombopoietin receptor agonists that stimulate platelet production, rituximab which slows antiplatelet antibody production, and in some cases, splenectomy. Spleen removal is generally considered only after failure of other treatments in children over age 5 with chronic ITP lasting at least 12 months.

Nursing care and management 🔗

Nurses play a vital role in caring for children with ITP. Comprehensive nursing care focuses on several priorities:

Assessment and monitoring 🔗

Regular assessment includes monitoring for signs of bleeding such as new petechiae, increasing bruises, or mucosal bleeding. Vital signs should be checked frequently, and neurological status monitored carefully since intracranial hemorrhage, though rare, is the most serious complication.

Bleeding prevention 🔗

Minimizing trauma is essential when platelet counts are low. The environment should be made as safe as possible, especially for young children. Use soft toothbrushes for oral care, and encourage soft foods to prevent mouth or gum bleeding. If the child gets a cut, apply clean gauze with pressure for at least five minutes.

Medication management 🔗

Nurses must ensure children avoid medications containing aspirin or ibuprofen as these increase bleeding risk. Acetaminophen should be used instead for pain relief. Intramuscular injections should be avoided when possible.

Administering treatments 🔗

When steroids or IVIG are prescribed, nurses monitor for side effects and response to treatment. Platelet counts are tracked to evaluate treatment effectiveness.

Family education and safety measures 🔗

Educating families is crucial for preventing complications at home. Key teaching points include:

Activity restrictions: Contact sports like soccer, football, rugby, and wrestling should be avoided, along with other high-injury activities. Children should wear helmets and protective pads when riding bicycles, skating, or skateboarding.

Medication awareness: Parents must understand to avoid giving aspirin and NSAIDs. All healthcare providers should be informed about the child’s ITP diagnosis.

Warning signs: Families should know when to seek immediate medical attention, particularly for signs of head injury, uncontrolled bleeding, or worsening symptoms.

Follow-up care: Regular blood tests to monitor platelet counts are essential. Parents should attend all recommended appointments.

Prognosis and outlook 🔗

The prognosis for children with ITP is generally excellent. In most children, the condition settles quite quickly, often without any treatment. The platelet count frequently rises to safe levels within a week or two. According to pediatric hematology data, about 80% of children will have platelet counts return to normal within two months, with or without therapy. Another 10% recover in the following months, while approximately 10% may develop chronic thrombocytopenia lasting beyond 12 months.

The body typically stops producing the antibodies attacking platelets, and the disorder resolves on its own. The goal of treatment is to maintain platelet counts at safe levels until the body corrects the problem, rather than achieving normal platelet counts. With appropriate care and prevention of serious injuries, children with ITP can live healthy, active lives.

What do you think? How might healthcare teams better support families in balancing normal childhood activities with safety precautions during periods of low platelet counts? What strategies have you found effective for helping children understand and cope with activity restrictions?

References

1. https://www.chop.edu/conditions-diseases/idiopathic-thrombocytopenic-purpura-itp
2. https://www.childrenshospital.org/conditions/immune-thrombocytopenia-itp
3. https://www.nationwidechildrens.org/conditions/health-library/immune-thrombocytopenic-purpura-in-children
4. https://www.childrensnational.org/get-care/health-library/idiopathic-thrombocytopenia-purpura-itp
5. https://ashpublications.org/bloodadvances/article/3/23/3829/429213/American-Society-of-Hematology-2019-guidelines-for
6. https://aob.amegroups.org/article/view/6316/html
7. https://www.nationwidechildrens.org/conditions/immune-thrombocytopenia-itp
8. https://kidshealth.org/en/parents/immune-thrombocytopenia.html
9. https://www.rch.org.au/kidsinfo/fact_sheets/Idiopathic_thrombocytopenic_purpura_ITP/